Prokidney PROK
NASDAQ PROK
$1.85 -0.14 (-7.04%)
At close: Sep 9, 2026 · 4:00 PM EDT

Prokidney (PROK) Construction in Progress (2021 - 2026)

Prokidney's (PROK) quarterly Construction in Progress came in at $21.7 million in Q2 2026, up 378.63% year-over-year from $4.5 million in Q2 2025, and up 12.29% quarter-over-quarter from $19.3 million in Q1 2026.

Analysis

Prokidney (PROK) Construction in Progress (2021 - 2026) Analysis & Trends

Prokidney (PROK) has reported Construction in Progress for 6 consecutive years, with $21.7 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Construction in Progress rose 378.63% year-over-year to $21.7 million in Q2 2026; TTM through Jun 2026 was $21.7 million, a 378.63% increase from a year earlier, with the FY2025 full-year figure at $14.7 million, up 500.94% from the prior year.
  • Construction in Progress was $21.7 million for Q2 2026 at Prokidney, up from $19.3 million in the prior quarter.
  • Over five years, Construction in Progress peaked at $21.7 million in Q2 2026 and troughed at $1.0 million in Q3 2022.
  • A 5-year average of $7.5 million and a median of $5.2 million in 2023 frame the typical range for Construction in Progress.
  • Across the five-year window, Construction in Progress soared 746.16% in 2023 and plunged 79.64% in 2024, its largest moves.
  • Over 5 years, Construction in Progress stood at $1.6 million in 2022, then surged by 441.57% to $8.7 million in 2023, then tumbled by 72.01% to $2.4 million in 2024, then surged by 500.94% to $14.7 million in 2025, then surged by 47.58% to $21.7 million in 2026.
  • The last three Construction in Progress figures came in at $21.7 million (Q2 2026), $19.3 million (Q1 2026), and $14.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn -
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn - -
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn -
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn -
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn -
6 Beam Therapeutics 2.65 Bn 2.65 Bn - -
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn 328,000.00
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn -
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn -
10 Prokidney 346.07 Mn 346.07 Mn - 21.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.70 Mn
Mar 31, 2026 19.33 Mn
Dec 31, 2025 14.71 Mn
Sep 30, 2025 10.17 Mn
Jun 30, 2025 4.53 Mn
Mar 31, 2025 3.73 Mn
Dec 31, 2024 2.45 Mn
Sep 30, 2024 3.56 Mn
Jun 30, 2024 1.19 Mn
Mar 31, 2024 9.08 Mn
Dec 31, 2023 8.74 Mn
Sep 30, 2023 8.49 Mn
Jun 30, 2023 5.86 Mn
Mar 31, 2023 3.24 Mn
Dec 31, 2022 1.61 Mn
Sep 30, 2022 1.00 Mn
Dec 31, 2021 351,000.00